Here is why Corcept Therapeutics Incorporated (CORT) stock volatility recorded over the last month was 7.65%

Let’s start up with the current stock price of Corcept Therapeutics Incorporated (CORT), which is $19.39 to be very precise. The Stock rose vividly during the last session to $23.48 after opening rate of $13.00 while the lowest price it went was recorded $12.81 before closing at $19.87.

Recently in News on August 5, 2020, Shuman Glenn & Stecker Investigates Corcept Therapeutics, Inc.. Shuman Glenn & Stecker announces that it is investigating potential shareholder claims against certain officers and directors of Corcept Therapeutics, Inc. (“Corcept” or the “Company”) (Nasdaq: CORT). Corcept is a pharmaceutical company. You can read further details here

Corcept Therapeutics Incorporated had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $23.48 on 09/02/20, with the lowest value was $9.70 for the same time period, recorded on 03/23/20.

Corcept Therapeutics Incorporated (CORT) full year performance was 60.24%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Corcept Therapeutics Incorporated shares are logging -17.42% during the 52-week period from high price, and 99.90% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $9.70 and $23.48.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 9601821 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Corcept Therapeutics Incorporated (CORT) recorded performance in the market was 64.21%, having the revenues showcasing 40.72% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 2.27B, as it employees total of 206 workers.

Analysts verdict on Corcept Therapeutics Incorporated (CORT)

During the last month, 3 analysts gave the Corcept Therapeutics Incorporated a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 1 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 14.78, with a change in the price was noted +7.87. In a similar fashion, Corcept Therapeutics Incorporated posted a movement of +65.80% for the period of last 100 days, recording 1,924,749 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CORT is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Corcept Therapeutics Incorporated (CORT): Technical Analysis

Raw Stochastic average of Corcept Therapeutics Incorporated in the period of last 50 days is set at 67.64%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 67.64%. In the last 20 days, the company’s Stochastic %K was 49.78% and its Stochastic %D was recorded 31.38%.

Let’s take a glance in the erstwhile performances of Corcept Therapeutics Incorporated, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 64.21%. Additionally, trading for the stock in the period of the last six months notably improved by 60.24%, alongside a boost of 60.24% for the period of the last 12 months. The shares increased approximately by 58.07% in the 7-day charts and went up by 26.64% in the period of the last 30 days. Common stock shares were driven by 40.72% during last recorded quarter.